Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Mesa Laboratories, Inc. before investing.

In this article, we go over a few key elements for understanding Mesa Laboratories, Inc.’s stock price such as:

• Mesa Laboratories, Inc.’s current stock price and volume
• Why Mesa Laboratories, Inc.’s stock price changed recently
• Upgrades and downgrades for MLAB from analysts
• MLAB’s stock price momentum as measured by its relative strength

About Mesa Laboratories, Inc. (MLAB)

Before we jump into Mesa Laboratories, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Want to learn more about Mesa Laboratories, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Mesa Laboratories, Inc..

Mesa Laboratories, Inc.’s Stock Price as of Market Close

As of April 24, 2026, 10:31 AM, CST, Mesa Laboratories, Inc.’s stock price was $97.450.

Mesa Laboratories, Inc. is up 0.57% from its previous closing price of $96.900.

During the last market session, Mesa Laboratories, Inc.’s stock traded between $95.210 and $97.450. Currently, there are approximately 5.53 million shares outstanding for Mesa Laboratories, Inc..

Mesa Laboratories, Inc.’s price-earnings (P/E) ratio is currently at 142.5, which is high compared to the Life Sciences Tools & Services industry median of 28. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Mesa Laboratories, Inc. Stock Price History

Mesa Laboratories, Inc.’s (MLAB) price is currently up 10.21% so far this month.

During the month of April, Mesa Laboratories, Inc.’s stock price has reached a high of $106.280 and a low of $86.510.

Over the last year, Mesa Laboratories, Inc. has hit prices as high as $131.200 and as low as $55.450. Year to date, Mesa Laboratories, Inc.’s stock is up 24.14%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Mesa Laboratories, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 23, 2026, there were 0 analysts who downgraded Mesa Laboratories, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Mesa Laboratories, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Mesa Laboratories, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Mesa Laboratories, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Mesa Laboratories, Inc. (MLAB) by visiting AAII Stock Evaluator.

Relative Price Strength of Mesa Laboratories, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 23, 2026, Mesa Laboratories, Inc. has a weighted four-quarter relative price strength of -2.96%, which translates to a Momentum Score of 45 and is considered to be Average.

Want to learn more about how Mesa Laboratories, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Mesa Laboratories, Inc. Stock Price: Bottom Line

As of April 24, 2026, Mesa Laboratories, Inc.’s stock price is $97.450, which is up 0.57% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Mesa Laboratories, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.